The committee members who voted yes generally believed the risks to be minimal, while those who voted no tended to worry about safety risks and effectiveness, and expressed concern that adding the peptide to the compounding list would create a false impression that it has been evaluated with the same rigorous standards as an FDA-approved drug
Krasilnikov, Cancer angiogenesis and opportunity of influence on tumor by changing vascularization
Vials (50 mg each, subcutaneous route only) One 50 mg vial lasts about 10 to 20 days at 2.5 to 5 mg per day
Similarly, amino acid injections can offer immediate benefits, particularly for those deficient in certain amino acids or engaging in intense physical activity
The same applies to BPC 157 immune system support
Additionally, PRP is an autologous component obtained from the patients body, indicating its natural and, thus, low-risk functionality